Cardlytics’ $76 Million Initial Public Offering

Cooley advised Cardlytics on its $75.7 million initial public offering of 5,821,355 shares of common stock, including 421,355 shares sold pursuant to the partial exercise of the underwriters’ overallotment option.

BofA Merrill Lynch and J.P. Morgan are acting as joint book-running managers and representatives of the underwriters for the offering. Wells Fargo Securities and SunTrust Robinson Humphrey are also acting as book-runners for the offering. Raymond James and KeyBanc Capital Markets are acting as co-managers for the offering.

Cardlytics, Inc. provides transaction-driven marketing solutions. The Company, led by Scott D Grimes, David T Evans and Lynne Laube, in 2017 recorded $130 Million Revenues.

Cardlytics, which now trades on the Nasdaq Global Market under the symbol “CDLX,” uses purchase intelligence to make marketing more relevant and measurable. It partners with more than 2,000 financial institutions to run their banking rewards programs that promote customer loyalty and deepen banking relationships.

Cooley advised with a team including Nicole Brookshire (Picture), Eric Jensen, Richard Segal, Lynn Horwitz, Esther Cho, Stephanie Gentile, Darren DeStefano and Jason Minio.

Involved fees earner: Nicole Brookshire – Cooley LLP; Eric Jensen – Cooley LLP; Richard Segal – Cooley LLP; Lynn Horwitz – Cooley LLP; Esther Cho – Cooley LLP; Darren DeStefano – Cooley LLP; Stephanie Gentile – Cooley LLP;

Law Firms: Cooley LLP;

Clients: Cardlytics Inc.;


Author: Ambrogio Visconti